Professional Documents
Culture Documents
Stakeholders: Identify health-focused civil society organizations patient & business Analytics: Research paper on the burden of chronic disease in Turkey by respected Turkish and International academic experts Public Policy: Engage the Turkish Ministry of Health (health Promotion and Prevention Branch)
to identify stakeholders with an interest in social and economic burden of chronic disease
Results:
79 organizations - including patients rights groups, foundations, economists and academics and health care provider groups with mandate related to access to healthcare 61 groups and individuals were selected for follow-up questionnaires and interviews
Stakeholder Audit
Interviews determined:
The therapeutic area of interest A key contact and leadership Corporate structure and governance Source of funding Visibility and/or level of activity Purpose, objective and primary activities
Stakeholder Engagement
Result
40-45 organizations invited to a workshop in Oct. 2012 to discuss burden of chronic disease in Turkey. Workshop participants:
Health Development Directorate of the Turkish Ministry of Health, Prof Mehtap Tatar Haceteppe University and study coauthor, patient advocacy leader from civil society organization in India, a representative of the Partnership to Fight Chronic Disease, a U.S.-based NGO.
Co-authors
Professor David Taylor and Dr. Sarah Carter , UCL School of Pharmacy Professor Dr. Mehtap Tatar, Hacettepe University Dr. Panos Kanavos and Dr. Federico Grimaccia and Dr. David Tordrup, LSE Health
Paper was shared with key officials from Turkeys Ministry of Health prior to release Turkey MoH participated in release of the paper at a press conference in Ankara
Transforming Health in Turkey: 21st Century Opportunities
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Our report places recent health advances in Turkey in context of global health improvement in the 20th century Recognizes opportunities for further improvement in the 21st century. Meant to share information, promote mutual understanding, not to impose external agenda on Turkish policy makers.
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Since 1970 life expectancy at birth has risen by 25 years and the infant death rate has fallen from about 150 to under 10 per 1000 live births However, rising rates of non-communicable disease and LTD causing welfare losses that cost more than current spending all all forms of health care Type 2 diabetes has doubled in little more than a decade, above the rate recorded in the US High vascular disease burdens, relatively high incidence of COPD and similar conditions
Transforming Health in Turkey: 21st Century Opportunities
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Policy makers across the world can help to facilitate positive active ageing through progressive public policy Prevention and treatment of chronic disease improves health at every stage in life, reduces the costs, and opens the way to increased economic productivity Turkey will benefit more from a healthy and active older population than a young population with sub-optimal treatment of long term illness
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Minimizing maternal mortality Promoting the rational use of medicines, smoking cessation, and exercise amongst both men and women
Use medicines to reduce blood pressure/ cholesterol and to prevent disabilities caused by diabetes or asthma to increase value in social circumstances As people age and transition socially they demand enhanced health/social services, and treatments for later life conditions such as cancers
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Rational Use of Rx
Turkeys Opportunities
Increase health investment from the current level of 6 per cent of GDP to the OECD average of 9 per cent Increase the use of pharmaceuticals as a cost effective health care option Increase the number of primary care professionals Promote innovative pharmacy based services
http://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
Advance sustainable-next generation chronic disease prevention, early intervention, and management models throughout the health care system and public health infrastructure Promote healthy lifestyles and disease prevention and management in every community Encourage and reward continuous advances in clinical practice and research that improve the quality of care for those with prevalent and costly chronic diseases
Accelerate improvements in the quality and availability of health information technology (HIT) throughout the health care system Reduce health disparities by focusing on barriers to good health